Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis.

This case-control study demonstrates that A. xylosoxidans occurs more frequently in the patients with the worse lung disease. Further studies assessing the pathogenicity of this emerging pathogen and international treatment recommendations are warranted.